Ayr scraps $55 million Chicago deal, Curaleaf cuts staff, Organigram receives delisting notice and Akerna moves out of the pot business altogether.
You are here: Home / Top Stories / Cannabis Watch: Is the cannabis gold rush over? Moves by Curaleaf, Ayr, Akerna and other companies point to tough times.